OBREDON is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Sovereign Pharmaceuticals, Llc. The primary component is Hydrocodone Bitartrate; Guaifenesin.
Product ID | 58716-433_7c47fb93-8438-2a78-e053-2991aa0a0993 |
NDC | 58716-433 |
Product Type | Human Prescription Drug |
Proprietary Name | OBREDON |
Generic Name | Hydrocodone Bitartrate And Guaifenesin |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2014-12-30 |
Marketing Category | NDA / NDA |
Application Number | NDA205474 |
Labeler Name | Sovereign Pharmaceuticals, LLC |
Substance Name | HYDROCODONE BITARTRATE; GUAIFENESIN |
Active Ingredient Strength | 3 mg/5mL; mg/5mL |
Pharm Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-12-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205474 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-12-30 |
Inactivation Date | 2020-01-31 |
Marketing Category | NDA |
Application Number | NDA205474 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-12-30 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
HYDROCODONE BITARTRATE | 2.5 mg/5mL |
SPL SET ID: | f73fdec5-d330-4d8c-894b-d0bcf5490624 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
58716-433 | OBREDON | Hydrocodone Bitartrate and Guaifenesin |
69101-620 | Hydrocodone Bitartrate and Guaifenesin | Hydrocodone Bitartrate and Guaifenesin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OBREDON 86461442 4847720 Live/Registered |
Sovereign Pharmaceuticals, LLC 2014-11-21 |